Table 1.
Clinical and surgical characteristics of 108 transgender women undergoing penoscrotal flap inversion vaginoplasty between 2015 and 2018.
| Clinical characteristics | |
| Age (years); mean (SD) | 36 ± 13 |
| ASA™ physical status (n = 106); mean (SD) | 1.6 ± 0.6 |
| Body mass index; mean (SD) | 25 ± 6.1 |
| Charlson Comorbidity Index; mean (SD) | 0.3 ± 0.9 |
| Duration of hormonal therapy (years; n = 92); mean (SD) | 3.1 ± 3.0 |
| Hx of circumcision; n (%) | 21 (19) |
| Diabetes mellitus; n (%) | 1 (0.93) |
| Hypertension; n (%) | 11 (10) |
| Coronary heart disease; n (%) | 1 (0.93) |
| Peripheral artery disease; n (%) | 1 (0.93) |
| Chronic obstructive pulmonary disease; n (%) | 2 (1.9) |
| Depression; n (%) | 22 (20) |
| Surgical characteristics | |
| Operative time (min); mean (SD) | 146 ± 23 |
| Length of stay (days); mean (SD) | 15 ± 3.4 |
| Preoperative hemoglobin (mg/dl); mean (SD) | 14 ± 0.9 |
| Postoperative hemoglobin (mg/dl); mean (SD) | 11 ± 1.1 |
| Difference preoperative—postoperative hemoglobin (mg/dl); mean (SD) | −2.8 ± 1.1 |
| Preoperative Qmax (ml/s; n = 98); mean (SD) | 29 ± 10 |
| Postoperative Qmax (ml/s; n = 34); mean (SD) | 23 ± 11 |
| Difference preoperative—postoperative Qmax (ml/s; n = 32); mean (SD) | −6.2 ± 11 |
| Intraoperative use of scrotal skin; n (%) | 14 (13) |
ASA, American Society of Anesthesiologists; SD, standard deviation.